Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure
Open Access
- 26 November 2013
- journal article
- research article
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 217
Abstract
The progression of heart failure is affected by several factors, including chronic stimulation of the β-adrenoceptor. This clinical study was designed to measure the effects of thoracic epidural analgesia (TEA) on the plasma levels of norepinephrine (NE), cAMP, and cGMP in patients with heart failure and assess the clinical implication of TEA. Forty patients with heart failure were randomly assigned to TEA (TEA plus standard care) and control groups (standard care). The plasma concentrations of cAMP, cGMP, brain natriuretic peptide (BNP), and NE were measured using ELISA before treatment, the second and fourth weeks of treatment. The plasma concentrations of cAMP, cGMP, BNP, and NE in the TEA group were significantly reduced by the fourth week compared to their initial concentrations (P < 0.01, for all parameters) and the control group (P < 0.05, P < 0.05, P < 0.01, and P < 0.05, respectively). The values for left ventricular end diastolic diameter (LVEDD), ejection fraction (EF), and fractional shortening (FS) in the TEA group improved significantly compared to their initial values and the control group. However, the changes in levels for these indices in the control group were no statistical significant compared to the initial levels. TEA can effectively decrease the plasma concentrations of cAMP and cGMP and improve cardiac function in patients with heart failure. The decreased levels of NE and cAMP occurred before the improvement in cardiac function, indicating that the abnormal epidural signal transduction can be corrected in patients with heart failure.Keywords
This publication has 30 references indexed in Scilit:
- Thoracic epidural analgesia for off-pump coronary artery bypass surgery in patients with chronic obstructive pulmonary diseaseAnnals of Cardiac Anaesthesia, 2010
- The Sympathetic Nervous System in Heart FailureJACC, 2009
- Increased muscle sympathetic nerve activity predicts mortality in heart failure patientsInternational Journal of Cardiology, 2009
- Use of a high thoracic epidural analgesia for treatment of end-stage congestive heart failure secondary to coronary artery diseaseInternational Journal of Cardiology, 2008
- Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failureNature Clinical Practice Cardiovascular Medicine, 2005
- Novel therapeutic approaches for heart failure by normalizing calcium cyclingNature Reviews Drug Discovery, 2004
- β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart FailureCirculation, 2003
- Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterasesCanadian Journal of Physiology and Pharmacology, 1999
- Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.Circulation, 1991
- Thoracic Epidural Anesthesia Improves Global and Regional Left Ventricular Function During Stress-Induced Myocardial Ischemia in Patients With Coronary Artery DiseaseAnesthesia & Analgesia, 1990